Keros Therapeutics, Inc. Accrued Income Taxes, Current
Keros Therapeutics, Inc. (KROS) had Accrued Income Taxes, Current of $4.15 million as of 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current › Taxes Payable, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2025-11-05
- 2025-09-30: Accrued Income Taxes, Current $4.15M.
- 2025-06-30: Accrued Income Taxes, Current $6.32M.
- 2025-03-31: Accrued Income Taxes, Current $10.04M.
- 2024-12-31: Accrued Income Taxes, Current $0.00.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2025-09-30 | $4.15M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $6.32M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $10.04M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |